Alzprotect
PrivateLast Round
Grant
Jun 1, 2022
Total Funding Raised
$26.29M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Alzprotect is a biopharmaceutical company that develops drug candidates for the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Progressive Supranuclear Palsy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alzprotect Comparables
Compare Alzprotect with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asceneuron | 85% | |
| Transposon Therapeutics | 79% | |
| Oligomerix, Inc. | 78% |
Alzprotect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2022 | ||||
| Corporate Funding | Jan 1, 2022 | ||||
| Series B | Jan 23, 2018 | ||||
| Series A Extension | Sep 21, 2016 | ||||
| Debt | Jun 11, 2014 | ||||
Series A | Jun 11, 2014 |
Key People
Founding team and executive leadership
Alzprotect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xerys | Corporate Funding, Series B |
| Invest Securities | Series A Extension |
| Finorpa | Seed |
| Siparex Group | Corporate Funding, Seed, Series A, Series A Extension |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Finovam Gestion | Corporate Funding, Series A, Series A Extension |
| Bpifrance | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 64% MoM, reaching 1.2K.
- May 1, 2025
Monthly visitors increased 744% MoM, from 59 to 498.
Alzprotect Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alzprotect's valuation, stock price, and market status.
Is Alzprotect a public or private company?
Alzprotect is a private company.
What is the current stock price of Alzprotect?
Alzprotect is a private company with no public stock price. No recent secondary market data is available.
How much is Alzprotect worth (valuation)?
Valuation information for Alzprotect is not publicly available.
Can I buy Alzprotect stock?
Alzprotect shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Alzprotect's last funding round?
Alzprotect's most recent funding round was Grant on June 1, 2022.
Who are the main investors in Alzprotect?
Key investors in Alzprotect include Xerys, Bpifrance.
Will Alzprotect IPO soon?
No public IPO plans have been announced for Alzprotect.
How can I track Alzprotect secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alzprotect's secondary market activity and sign up for updates.